Seroprevalence of Trypanosoma cruzi (TC) and risk factors in Colima, Mexico.

INTRODUCTION The present study was conducted to estimate the incidence of seropositivity to anti-Trypanosoma cruzi antibodies and analyze potential risk factors in Colima, on the western coast of Mexico. METHODOLOGY Longitudinal studies of 209 subjects with negative serology in 1999 for anti-Trypanosoma cruzi antibodies by hemagglutination inhibition test were tested again in 2005. At the same time, 716 children under six years of age were surveyed serologically (total n = 925); the history of Trypanosoma cruzi infection was determined by the same hemagglutination inhibition test. The variables analyzed were age, sex, living in triatomine-infested places, type of community, quality of housing, presence of pets, and number of inhabitants per house. RESULTS Trypanosoma cruzi seropositivity in the period of six years was 22/925 cases, with a point prevalence of 2.73% and an adjusted rate of 7.3/1,000 person-years. The variable living in triatomine-infested areas showed association with seropositivity anti-Trypanosoma cruzi antibodies (RR: 5.5; 95% CI: 1.28-23.5). The remaining variables showed no significant association. CONCLUSIONS This study confirms the active transmission of Chagas disease in Mexico´s western-central region, which merits greater epidemiological surveillance and vector control, particularly in localities infested with triatomines.

[1]  M. Picollo,et al.  Insecticide resistance in vector Chagas disease: evolution, mechanisms and management. , 2015, Acta tropica.

[2]  L. Duarte,et al.  Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in chronic phase of Chagas disease , 2014, Colombia medica.

[3]  M. E. Berne,et al.  Conventional serological performance in diagnosis of Chagas’ disease in southern Brazil , 2013, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[4]  P. Hotez,et al.  Bridging the innovation gap for neglected tropical diseases in México: capacity building for the development of a new generation of antipoverty vaccines , 2011 .

[5]  David M. Frank,et al.  Chagas Disease Risk in Texas , 2010, PLoS neglected tropical diseases.

[6]  J. Muñoz,et al.  Congenital transmission of Chagas disease: a clinical approach , 2010, Expert review of anti-infective therapy.

[7]  S. Wendel Transfusion transmitted Chagas disease: is it really under control? , 2010, Acta tropica.

[8]  A. Silveira,et al.  Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. , 2009, Memorias do Instituto Oswaldo Cruz.

[9]  P. Buekens,et al.  Mother-to-Child Transmission of Chagas’ Disease in North America: Why Don’t We Do More? , 2008, Maternal and Child Health Journal.

[10]  Alejandro Cruz-Reyes,et al.  Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years--a review. , 2006, Memorias do Instituto Oswaldo Cruz.

[11]  J M Ramsey,et al.  Risk factors associated with house infestation by the Chagas disease vector Triatoma pallidipennis in Cuernavaca metropolitan area, Mexico , 2005, Medical and veterinary entomology.

[12]  F. Espinoza-Gomez,et al.  Active transmission of human chagas disease in Colima Mexico. , 2004, Memorias do Instituto Oswaldo Cruz.

[13]  J. Dias,et al.  The impact of Chagas disease control in Latin America: a review. , 2002, Memorias do Instituto Oswaldo Cruz.

[14]  P. M. Schettino,et al.  Iniciativa México: Propuesta para el control y vigilancia epidemiológica de la enfermedad de Chagas en México , 2001 .

[15]  F. Zicker,et al.  Evaluation of risk factors for house infestation by Triatoma infestans in Brazil. , 1995, The American journal of tropical medicine and hygiene.

[16]  M. L. Belaunzarán [Chagas disease: Globalization and new hope for its cure]. , 2015, Revista Argentina de microbiologia.

[17]  J. C. Vazquez-Chagoyán,et al.  Risk factors associated with triatomines and its infection with Trypanosoma cruzi in rural communities from the southern region of the State of Mexico, Mexico. , 2010, The American journal of tropical medicine and hygiene.

[18]  R. Tapia,et al.  [Seroprevalence of Trypanosoma cruzi antibodies and associated risk factors among the population under 18 years of age in Veracruz, Mexico]. , 2007, Revista panamericana de salud publica = Pan American journal of public health.

[19]  P. Reyes,et al.  Factores bióticos y abióticos que determinan la seroprevalencia de anticuerpos contra Trypanosoma Cruzi en el municipio de Palmar de Bravo, Puebla, México , 2004 .

[20]  Por Vector NORMA Oficial Mexicana NOM-032-SSA2-2002, Para la vigilancia epidemiológica, prevención y control de enfermedades transmitidas por vector. , 2002 .

[21]  I. Fernández-Salas,et al.  Presence of triatominae (Hemiptera, Reduviidae) and risk of transmission of Chagas disease in Colima, México. , 2002, Memorias do Instituto Oswaldo Cruz.

[22]  J. Blejer,et al.  [Prevalence of Trypanosoma cruzi antibodies in blood donors]. , 1999, Medicina.

[23]  C. Schofield A comparison of sampling techniques for domestic populations of Triatominae. , 1978, Transactions of the Royal Society of Tropical Medicine and Hygiene.